[1] LEE RC，FEINBAUM RL，AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell，1993，75（5）:843-854.
[2] LEWIS BP，BURGE CB，BARREL DP. Conserved seed pairing，often flanked by adenosines，indicates that thousands of human genes are microRNA targets[J]. Cell，2005，120（1）:l5-20.
[3] SAGE C，AGAMI R. Immense promises for tiny molecules uncovering miRNA functions[J]. Cell Cycle，2006，5（13）:1-7.
[4] CALIN GA，CROCE CM. MicroRNA-cancer connection: the beginning of a new life[J]. Cancer Res，2006，66（15）:7390-7394.
[5] JOPLING CL，NORMAN KL，SARNOW P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122[J]. Cold Spring Harb Symp Quant Biol，2006，71:369-376.
[6] CAI X，HAGEDORN CH，CULLEN BR，et al. Human microRNAs are processed from capped，polyadenylated transcripts that can also function as mRNAs[J]. RNA，2004，10（12）:1957-1966.
[7] HAN J，LEE Y，YEOM KH，et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex[J]. Cell，2006，125（5）:887-901.
[8] LUND E，GUTTINGER S，CALADO A，et al. Nuclear export of microRNA precursor[J]. Science，2004，303（5654）:95-98.
[9] CHENDRIMADA TP，GREGORY RI，KUMARASWAMY E，et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing[J]. Nature，2005，436（7051）:740-744.
[10] DOENCH JG，PETERSON CP，SHARP PA. siRNAs can function as miRNAs[J]. Genes Dev，2003，17:438-442.
[11] ZENG Y，YI R，CUHEN BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms[J]. Proc Natl Acad Sci USA，2003，100（17）:9779-9784.
[12] MOROY T，ETIEMBLE J，BOUGUELERET L，et al. Structure and expression of hcr，a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma[J]. Oncogene，1989，4（1）:59-65.
[13] LAGOS-QUINTANA M，RAUHUT R，YALCIN A，et al. Identification of tissue-specific microRNAs from mouse[J]. Curr Biol，2002，12（9）:735-739.
[14] CHANG J，NICOLAS E，MARKS D，et al. miR-122，a mammalian liver-specific microRNA，is processed from hcr mRNA and may downregulate the high affinitycationic amino acid transporter CAT-1[J]. RNA Biol，2004，1（2）:106-113.
[15] JOPLING CL，YI M，LANCASTER AM，et al. Modulation of hepatitis C virus RNA abundance by a liver specific MicroRNA[J]. Science，2005，309（5740）:1577-1581.
[16] HATZOGLOU M，FERNANDEZ J，YAMAN I，et al. Regulation of cationic amino acid transport: the story of the CAT-1 transporter[J]. Annu Rev Nutr，2004，24:377-399.
[17] BHATTACHARYYA SN，HABERMACHER R，MARTINE U，et al. Relief of microRNA-mediated translational repression in human cells subjected to stress[J]. Cell，2006，125（6）:1036-1038.
[18] KRUTZFELDT J，RAJEWSKY N，BRAICH R，et al. Silencing of microRNAs in vivo with“antagomRs”[J]. Nature，2005，438（7068），685-689.
[19] ESAU C，DAVIS S，MURRAY SF，et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J]. Cell Metab，2006，3（2），87-98.
[20] JOPLING CL，SCHUTZ S，SARNOW P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome[J]. Cell Host Microbe，2008，4（1）:77-85.
[21] JOPLING CL. Regulation of hepatitis C virus by microRNA-122[J]. Biochem Soc Trans，2008，36（Pt6），1220-1223.
[22] HENKE JI，GOERGEN D，ZHENG J，et al. MicroRNA-122 stimulates translation of hepatitis C virus RNA[J]. EMBO J，2008，27（24）:3300-3310.
[23] DIAZ-TOLEDANO R，ARIZA-MATEOS A，BIRK A，et al. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5’region of hepatitis C virus RNA[J]. Nucleic Acids Res，2009，37（16）:5498-5510.
[24] SHAN Y，ZHENG J，LAMBRECHT RW，et al. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes[J]. Gastroenterology，2007，133（4）:1166-1174.
[25] KUTAY H，BAI S，DATTA J，et al. Down regulation of miR-122 in the rodent and human hepatocellular carcinomas[J]. J Cell Biochem，2006，99（3）:671-678.
[26] 骆明勇，杨戎，张亮，等. MicroRNA 122对肝癌细胞基因表达谱的影响[J]. 中国生物化学与分子生物学报，2007，23（8）：644-651.
[27] GRAMANTIERI L，FERRACIN M，FORNARI F，et al. Cyclin G1 is a target of miR-122a，a microRNA frequently down-regulated in human hepatocellular carcinoma[J]. Cancer Res，2007，67（13）:6092-6099.
[28] PEREZ R，WU N，KLIPFEL AA，et al. A better cell cycle target for gene therapy of colorectal cancer: cyclin G[J]. J Gastrointest Surg，2003，7（7）:884-889.
[29] BAEK WK，KIM D，JUNG N，et al. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium[J]. Am J Obstet Gynecol，2003，188（3）:634-639.
[30] FORNARI F，GRAMANTIERI L，GIOVANNINI C，et al. miR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res，2009，69（14）:5761-5617.
[31] LIN CJ，GONG HY，TSENG HC，et al. miR-122 targets an anti-apoptotic gene，Bcl-w，in human hepatocellular carcinoma cell lines[J]. Biochem Biophys Res Commun，2008，375（3）:315-320.
[32] BAI S，NASSER MW，WANG B，et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib[J]. J Biol Chem，2009，284（46）:32015-32027.
[33] PEDERSEN IM，CHENG GF，WIELAND S，et al. Interferon modulation of cellular microRNAs as an antiviral mechanism[J]. Nature，2007，449（7164）:919-922.
[34] LANFORD RE，HILDEBRANDT-ERIKSEN ES，PETRI A，et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection[J]. Science，2010，327（5962）:198-201. |
